Annual Net Margin
-68.36%
+22.89%+25.08%
December 31, 2023
Summary
- As of February 25, 2025, BCRX annual net profit margin is -68.36%, with the most recent change of +22.89% (+25.08%) on December 31, 2023.
- During the last 3 years, BCRX annual net margin has risen by +957.99% (+93.34%).
- BCRX annual net margin is now -279.15% below its all-time high of -18.03%, reached on December 31, 2009.
Performance
BCRX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-11.99%
-0.40%-3.45%
September 30, 2024
Summary
- As of February 25, 2025, BCRX quarterly net profit margin is -11.99%, with the most recent change of -0.40% (-3.45%) on September 30, 2024.
- Over the past year, BCRX quarterly net margin has stayed the same.
- BCRX quarterly net margin is now -126.64% below its all-time high of 45.00%, reached on September 30, 1998.
Performance
BCRX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
BCRX Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.1% | 0.0% |
| 3 y3 years | +93.3% | +91.6% |
| 5 y5 years | +86.1% | +99.4% |
BCRX Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.6% | -3.5% | +91.9% |
| 5 y | 5-year | at high | +93.3% | -81.7% | +99.2% |
| alltime | all time | -279.1% | +99.6% | -126.6% | +100.0% |
BioCryst Pharmaceuticals Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -11.99%(+3.5%) |
| Jun 2024 | - | -11.59%(-69.6%) |
| Mar 2024 | - | -38.14%(-42.3%) |
| Dec 2023 | -68.36%(-25.1%) | -66.09%(+58.6%) |
| Sep 2023 | - | -41.67%(-54.4%) |
| Jun 2023 | - | -91.31%(+17.8%) |
| Mar 2023 | - | -77.54%(-13.8%) |
| Dec 2022 | -91.25%(-22.1%) | -89.94%(+60.4%) |
| Sep 2022 | - | -56.08%(-37.6%) |
| Jun 2022 | - | -89.82%(-39.6%) |
| Mar 2022 | - | -148.62%(+294.2%) |
| Dec 2021 | -117.11%(-88.6%) | -37.70%(-73.7%) |
| Sep 2021 | - | -143.44%(+65.9%) |
| Jun 2021 | - | -86.47%(-74.4%) |
| Mar 2021 | - | -337.29%(-77.6%) |
| Dec 2020 | -1026.35%(+360.3%) | -1506.30%(+99.3%) |
| Sep 2020 | - | -755.74%(-43.8%) |
| Jun 2020 | - | -1344.72%(+72.5%) |
| Mar 2020 | - | -779.58%(>+9900.0%) |
| Dec 2019 | -222.99%(-54.5%) | -6.60%(-99.7%) |
| Sep 2019 | - | -2117.86%(-18.5%) |
| Jun 2019 | - | -2598.69%(+392.6%) |
| Mar 2019 | - | -527.50%(-47.5%) |
| Dec 2018 | -490.25%(+87.7%) | -1005.20%(-50.6%) |
| Sep 2018 | - | -2035.56%(+1278.7%) |
| Jun 2018 | - | -147.64%(-77.2%) |
| Mar 2018 | - | -648.31%(+29.0%) |
| Dec 2017 | -261.18%(+24.8%) | -502.39%(+190.8%) |
| Sep 2017 | - | -172.76%(-68.3%) |
| Jun 2017 | - | -544.89%(+261.6%) |
| Mar 2017 | - | -150.67%(+200.6%) |
| Dec 2016 | -209.25%(+134.7%) | -50.13%(-66.2%) |
| Sep 2016 | - | -148.50%(-56.3%) |
| Jun 2016 | - | -340.11%(-28.2%) |
| Mar 2016 | - | -473.69%(+20.2%) |
| Dec 2015 | -89.15%(-73.2%) | -394.07%(+196.1%) |
| Sep 2015 | - | -133.08%(-801.5%) |
| Jun 2015 | - | 18.97%(-108.5%) |
| Mar 2015 | - | -222.15%(+3.7%) |
| Dec 2014 | -332.08%(+91.2%) | -214.32%(-20.5%) |
| Sep 2014 | - | -269.64%(-73.0%) |
| Jun 2014 | - | -999.25%(+240.9%) |
| Mar 2014 | - | -293.15%(+470.6%) |
| Dec 2013 | -173.72%(+16.9%) | -51.38%(-84.7%) |
| Sep 2013 | - | -334.91%(-77.4%) |
| Jun 2013 | - | -1482.58%(+1069.3%) |
| Mar 2013 | - | -126.79%(-53.0%) |
| Dec 2012 | -148.64%(-48.7%) | -269.52%(+60.1%) |
| Sep 2012 | - | -168.37%(-42.3%) |
| Jun 2012 | - | -291.59%(+488.8%) |
| Mar 2012 | - | -49.52%(-80.4%) |
| Dec 2011 | -289.92%(+434.2%) | -252.53%(-8.3%) |
| Sep 2011 | - | -275.46%(-36.8%) |
| Jun 2011 | - | -435.64%(+81.8%) |
| Mar 2011 | - | -239.69%(+292.2%) |
| Dec 2010 | -54.27%(+201.0%) | -61.11%(-32.5%) |
| Sep 2010 | - | -90.53%(-32.4%) |
| Jun 2010 | - | -133.84%(+1245.1%) |
| Mar 2010 | - | -9.95%(-136.1%) |
| Dec 2009 | -18.03% | 27.60%(-127.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | -100.75%(-44.5%) |
| Jun 2009 | - | -181.41%(-14.9%) |
| Mar 2009 | - | -213.17%(-824.8%) |
| Dec 2008 | -43.73%(+7.2%) | 29.41%(-129.1%) |
| Sep 2008 | - | -101.14%(-78.8%) |
| Jun 2008 | - | -477.96%(+292.9%) |
| Mar 2008 | - | -121.64%(+1399.9%) |
| Dec 2007 | -40.79%(-94.2%) | -8.11%(-84.9%) |
| Sep 2007 | - | -53.68%(+3.6%) |
| Jun 2007 | - | -51.79%(-46.2%) |
| Mar 2007 | - | -96.35%(-79.9%) |
| Dec 2006 | -702.16%(-95.9%) | -480.41%(-44.9%) |
| Sep 2006 | - | -871.68%(+34.7%) |
| Jun 2006 | - | -647.18%(-36.7%) |
| Mar 2006 | - | -1022.31%(-97.0%) |
| Dec 2005 | -17.19 K%(+174.3%) | -34.32 K%(+43.6%) |
| Sep 2005 | - | -23.89 K%(+145.3%) |
| Jun 2005 | - | -9737.93%(-29.3%) |
| Mar 2005 | - | -13.77 K%(+363.1%) |
| Dec 2004 | -6264.19%(+222.2%) | -2973.07%(-34.9%) |
| Sep 2004 | - | -4565.52%(-61.2%) |
| Jun 2004 | - | -11.76 K%(+665.9%) |
| Dec 2003 | -1944.12%(+4250.2%) | - |
| Sep 2003 | - | -1535.59%(+25.6%) |
| Jun 2003 | - | -1222.56%(+35.1%) |
| Mar 2003 | - | -905.19%(+9.2%) |
| Sep 2002 | - | -828.88%(-20.4%) |
| Mar 2002 | - | -1041.93%(+616.0%) |
| Dec 2001 | -44.69%(-87.2%) | -145.53%(-1287.0%) |
| Sep 2001 | - | 12.26%(-53.5%) |
| Jun 2001 | - | 26.36%(-113.4%) |
| Mar 2001 | - | -196.73%(-14.2%) |
| Dec 2000 | -349.19%(+64.7%) | -229.20%(+78.4%) |
| Sep 2000 | - | -128.44%(+14.3%) |
| Jun 2000 | - | -112.41%(-91.5%) |
| Mar 2000 | - | -1316.31%(-99.4%) |
| Dec 1999 | -212.00%(+182.7%) | - |
| Sep 1999 | - | -220.00 K%(>+9900.0%) |
| Jun 1999 | - | -13.69%(-97.1%) |
| Mar 1999 | - | -480.00%(+28.0%) |
| Dec 1998 | -75.00%(-92.9%) | -375.00%(-933.3%) |
| Sep 1998 | - | 45.00%(-101.5%) |
| Jun 1998 | - | -3000.00%(0.0%) |
| Mar 1998 | - | -3000.00%(+20.0%) |
| Dec 1997 | -1060.00%(+120.3%) | - |
| Sep 1997 | - | -2500.00%(+1090.5%) |
| Jun 1997 | - | -210.00%(-93.2%) |
| Mar 1997 | - | -3100.00%(+272.0%) |
| Dec 1996 | -481.25%(-88.8%) | - |
| Sep 1996 | - | -833.33%(+1080.5%) |
| Jun 1996 | - | -70.59%(-96.3%) |
| Mar 1996 | - | -1900.00%(-13.6%) |
| Dec 1995 | -4300.00%(+336.2%) | -2200.00%(+15.8%) |
| Sep 1995 | - | -1900.00%(+18.8%) |
| Jun 1995 | - | -1600.00%(+10.3%) |
| Mar 1995 | - | -1450.00%(+61.1%) |
| Dec 1994 | -985.71% | -900.00%(+12.5%) |
| Sep 1994 | - | -800.00%(-57.9%) |
| Jun 1994 | - | -1900.00%(+18.8%) |
| Mar 1994 | - | -1600.00% |
FAQ
- What is BioCryst Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual net margin year-on-year change?
- What is BioCryst Pharmaceuticals quarterly net profit margin?
- What is the all time high quarterly net margin for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly net margin year-on-year change?
What is BioCryst Pharmaceuticals annual net profit margin?
The current annual net margin of BCRX is -68.36%
What is the all time high annual net margin for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual net profit margin is -18.03%
What is BioCryst Pharmaceuticals annual net margin year-on-year change?
Over the past year, BCRX annual net profit margin has changed by +22.89% (+25.08%)
What is BioCryst Pharmaceuticals quarterly net profit margin?
The current quarterly net margin of BCRX is -11.99%
What is the all time high quarterly net margin for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly net profit margin is 45.00%
What is BioCryst Pharmaceuticals quarterly net margin year-on-year change?
Over the past year, BCRX quarterly net profit margin has changed by 0.00% (0.00%)